Specialty injectable are used for treating chronic diseases like HIV, cancer, hemophilia, cardiovascular diseases and infectious diseases. These specialty injectables are very expensive and they require appropriate temperature, special handling and clinical management. These are administered using an injection. Specialty injectables are required to be used with counselling, monitoring or surveillance. As these are expensive injectable drugs, they require proper temperature control, clinical management and special handling for ensuring the performance of drug.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4971
Impact of COVID-19 pandemic:
COVID-19 was first reported in China on December 31, 2019 and it was declared a pandemic by the World Health Organization on March 11, 2020. According to a report by the WHO, 271 million positive cases of COVID-19 and 5,331,019 deaths have been reported till December, 2021.
Increased research and developmental activities by the key players in the market is expected to fuel growth of the global specialty injectable market growth over the forecast period. For instance, in May 17, 2021, the Sanofi and GSK recombinant COVID-19 vaccine has shown strong antibody responses, as compared to those patients treated with SARS-CoV virus.
Rise in the number of approvals by the regulatory authorities is expected to boost the growth of the global specialty injectable market during the forecast period. For instance, in September 2021, a pharmaceutical firm, Aurobindo Pharma Ltd. received the U.S. Food and Drug Administration (FDA) approval for the manufacture and marketing of Cyclophosphamide Injection, and they will be manufacturing 1g/5mL and 500mg/2.5 mL vials, which can be used for malignant lymphomas, Leukemia, retinoblastoma and breast cancer.
Furthermore, regulatory authorities are increasingly granting approvals to products, which is projected to fuel the growth of the global specialty injectable market growth during the forecast period. For instance, the U.S. FDA approved Wegovy injection on June 4, 2021, for adults with high blood pressure, obesity, type 2 diabetes, high cholesterol or obesity.
Increased incidences of chronic diseases is likely to boost the global specialty injectable market growth over the forecast period. For instance, in September 2021, WHO published a fact sheet and reported that cancer was the leading cause of death globally. Cancer was responsible for nearly 10 million deaths in 2020, and diabetes accounted for 1.5 million death, diabetes being the ninth leading cause for death.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4971
- Increase in growth of potential markets in regions such as North America and Europe is anticipated to propel growth of the global specialty injectable market during the forecast period.
- Many key market players are presenting their researches at various conferences. For instance, Smi Group Ltd, arranges business to business conferences and a conference for the key players was arranged on January 13-14, 2022, at Imperial College of London in the United Kingdom, it involved manufacturing of injectable drug devices and pre filled syringes.
Major key players active in the global specialty injectable market are Teva Pharmaceutical Industries Ltd, Cipla Limited, Fresenius SE & Co. KGaA, Eli Lilly and Company, Mylan N.V, Hikma Pharmaceuticals PLC, Novartis AG, Sun Pharmaceutical Industries Limited, AstraZeneca, Pfizer Inc, Endo International Plc, Genzyme Corporation, Amgen Inc, Alnylam Pharmaceuticals Inc, Genentech USA Inc, Merck & Co. Inc, Dr. Reddy’s Laboratories, Sagent Pharmaceuticals Inc, Fresenius SE & Co, Lupin Ltd, and Biogen.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Specialty Injectable Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Specialty Injectable Industry Impact
Chapter 2 Global Specialty Injectable Competition by Types, Applications, and Top Regions and Countries
2.1 Global Specialty Injectable (Volume and Value) by Type
2.3 Global Specialty Injectable (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Specialty Injectable Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Specialty Injectable Market Analysis
Chapter 6 East Asia Specialty Injectable Market Analysis
Chapter 7 Europe Specialty Injectable Market Analysis
Chapter 8 South Asia Specialty Injectable Market Analysis
Chapter 9 Southeast Asia Specialty Injectable Market Analysis
Chapter 10 Middle East Specialty Injectable Market Analysis
Chapter 11 Africa Specialty Injectable Market Analysis
Chapter 12 Oceania Specialty Injectable Market Analysis
Chapter 13 South America Specialty Injectable Market Analysis
Chapter 14 Company Profiles and Key Figures in Specialty Injectable Business
Chapter 15 Global Specialty Injectable Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4971
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027